Sernova Corp - Company Profile
Powered by 
All the data and insights you need on Sernova Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Sernova Corp Strategy Report
- Understand Sernova Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Sernova Corp (Sernova) is a clinical-stage biotechnology company that develops and commercializes novel products for the treatment of chronic disease indications. The company develops technologies including Cell Pouch and related technologies including therapeutic cells. Srnova develops technologies to treat diseases such as diabetes, Hemophilia, hypothyroid, metabolic diseases, blood disorders, and other diseases.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company R&D efforts focus on developing technologies and study clinical trials of its pipeline products for the treatment of diabetes, Hemophilia, metabolic diseases, blood disorders, and other diseases. -Major pipeline products include human donor islets, micro-encapsulated islets; microencapsulated stem cell derived cells; corrected patient cells; allograft immune protected cells; and autograft thyroid cells. -Its major technologies include Cell Pouch System and immune protection technology. -In FY2023, the company spent CAD32.04 million on its R&D activities, which grew 89.6% YoY.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer